• FAQS
  • ABOUT
  • LOG IN
  • SIGN UP

ALPN Overview

Upcoming Projects (ALPN) Image
  • Don’t see a project related to the company you care about? Create your own!

Executed Projects (ALPN) Image
  • A Second Look: Examining the potential of Alpine Immune Sciences' povetacicept in treating autoimmune glomerulonephritis
    Ticker: ALPN
    Executed On: Jan 18, 2024 at 01:00 PM EST
  • Examining the potential of Alpine Immune Sciences' povetacicept in treating autoimmune glomerulonephritis
    Ticker: ALPN
    Executed On: Jan 11, 2024 at 04:00 PM EST
Upcoming & Overdue Catalysts (ALPN) Image
  • Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (ALPN) Image
  • Alpine Immune Sciences (ALPN) and Horizon Therapeutics (HZNP) Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases
    Tickers: ALPN, HZNP
    Announcement Date: Dec 16, 2021
  • Alpine Immune Sciences (ALPN) discloses that Gilead Sciences' (GILD) Kite Pharma will terminate their October 2015 license and research agreement aimed at developing protein-based immunotherapies for cancer effective June 20
    Tickers: ALPN, GILD
    Announcement Date: May 24, 2019
About Us
  • About
  • Pricing
  • Compliance
  • Terms of Use
  • Privacy Policy
Media Center
  • Jobs
Connect with Us
  • facebook Facebook
  • facebook Twitter
  • facebook LinkedIn
  • facebook Email Us
© 2025 Slingshot Insights. All rights reserved.